EGFR is an important glycoprotein for cancer biology with a significant number of glycosylation sites (7–13 N-glycosylations in the extracellular domain); it is highly expressed in different cancers and is considered a proteomic marker [76,77,78,79]. This evidence concerns the gene ART4 and cancer.